Yue Yan

CV
h-index37
3papers
3citations
Novelty42%
AI Score39

3 Papers

CVDec 7, 2025
TextMamba: Scene Text Detector with Mamba

Qiyan Zhao, Yue Yan, Da-Han Wang

In scene text detection, Transformer-based methods have addressed the global feature extraction limitations inherent in traditional convolution neural network-based methods. However, most directly rely on native Transformer attention layers as encoders without evaluating their cross-domain limitations and inherent shortcomings: forgetting important information or focusing on irrelevant representations when modeling long-range dependencies for text detection. The recently proposed state space model Mamba has demonstrated better long-range dependencies modeling through a linear complexity selection mechanism. Therefore, we propose a novel scene text detector based on Mamba that integrates the selection mechanism with attention layers, enhancing the encoder's ability to extract relevant information from long sequences. We adopt the Top\_k algorithm to explicitly select key information and reduce the interference of irrelevant information in Mamba modeling. Additionally, we design a dual-scale feed-forward network and an embedding pyramid enhancement module to facilitate high-dimensional hidden state interactions and multi-scale feature fusion. Our method achieves state-of-the-art or competitive performance on various benchmarks, with F-measures of 89.7\%, 89.2\%, and 78.5\% on CTW1500, TotalText, and ICDAR19ArT, respectively. Codes will be available.

CVAug 10, 2025Code
ASM-UNet: Adaptive Scan Mamba Integrating Group Commonalities and Individual Variations for Fine-Grained Segmentation

Bo Wang, Mengyuan Xu, Yue Yan et al.

Precise lesion resection depends on accurately identifying fine-grained anatomical structures. While many coarse-grained segmentation (CGS) methods have been successful in large-scale segmentation (e.g., organs), they fall short in clinical scenarios requiring fine-grained segmentation (FGS), which remains challenging due to frequent individual variations in small-scale anatomical structures. Although recent Mamba-based models have advanced medical image segmentation, they often rely on fixed manually-defined scanning orders, which limit their adaptability to individual variations in FGS. To address this, we propose ASM-UNet, a novel Mamba-based architecture for FGS. It introduces adaptive scan scores to dynamically guide the scanning order, generated by combining group-level commonalities and individual-level variations. Experiments on two public datasets (ACDC and Synapse) and a newly proposed challenging biliary tract FGS dataset, namely BTMS, demonstrate that ASM-UNet achieves superior performance in both CGS and FGS tasks. Our code and dataset are available at https://github.com/YqunYang/ASM-UNet.

CVJan 29, 2025
An Exceptional Dataset For Rare Pancreatic Tumor Segmentation

Wenqi Li, Yingli Chen, Keyang Zhou et al.

Pancreatic NEuroendocrine Tumors (pNETs) are very rare endocrine neoplasms that account for less than 5% of all pancreatic malignancies, with an incidence of only 1-1.5 cases per 100,000. Early detection of pNETs is critical for improving patient survival, but the rarity of pNETs makes segmenting them from CT a very challenging problem. So far, there has not been a dataset specifically for pNETs available to researchers. To address this issue, we propose a pNETs dataset, a well-annotated Contrast-Enhanced Computed Tomography (CECT) dataset focused exclusively on Pancreatic Neuroendocrine Tumors, containing data from 469 patients. This is the first dataset solely dedicated to pNETs, distinguishing it from previous collections. Additionally, we provide the baseline detection networks with a new slice-wise weight loss function designed for the UNet-based model, improving the overall pNET segmentation performance. We hope that our dataset can enhance the understanding and diagnosis of pNET Tumors within the medical community, facilitate the development of more accurate diagnostic tools, and ultimately improve patient outcomes and advance the field of oncology.